Page 34 - Martin Marietta - 2024 Proxy Statement
P. 34
PROPOSAL 1: ELECTION OF DIRECTORS / DIRECTOR NOMINEES
Ms. Perez is an investment consultant with DeRoy & Devereaux, an Key attributes,
independent investment adviser, where she has provided client experience and skills:
consulting services since 2015. She was previously Owner and
Managing Partner of The Medallion Company, LLC, a consulting • Significant business, financial
firm, from 2003 to 2015. Ms. Perez was previously a Director of and private investment
GenOn Energy, Inc. (NYSE: GEN), one of the largest power experience
producers in the United States, from 2002 to 2012, and served as • Significant expertise with respect
the Chairman of the Audit Committee of GenOn Energy, Inc. from to financial statements,
2002 to 2007 and a member of its Audit and Risk and Finance corporate finance, accounting
Oversight Committees from 2008 to 2012. Previously, she was Vice and capital markets, mergers and
President of Loomis, Sayles & Company, L.P. and co-founder, acquisitions, and strategic
analysis
LAREE E. President and Chief Executive Officer of Medallion Investment • Insight into auditing best
Company, Inc. In addition to civic and charitable organizations,
PEREZ Ms. Perez served as Vice Chairman of the Board of Regents at practices
Baylor University and previously served on the Board of Trustees of
Director Since: 2004 New Mexico State University, where she was also Chairman of the • Familiarity with the southwestern
Age: 70 Board. Ms. Perez earned a Bachelor’s degree from Baylor University United States
Committees: in Finance and Economics.
Mr. Pike joined the Martin Marietta Board in July 2019 and is Key attributes,
currently Chairman and Chief Executive Officer of Fortrea experience and skills:
(Nasdaq: FTRE) having served in this role since Fortrea’s launch as
an independent company in July 2023. Mr. Pike joined Fortrea as • More than 15 years of C-Suite
President and Chief Executive Officer in January 2023 during its experience
spinoff from its parent company Labcorp (NYSE: LH). Mr. Pike has • Broad strategic and financial
more than 30 years of leadership experience in global services, experience
most notably in the contract research organization (CRO) industry. • Extensive experience in mergers
Previously, Mr. Pike served as Chief Executive Officer and a and acquisitions, integration, and
member of the Board of Directors of Quintiles Transnational strategic development and
Holdings, Inc. (Quintiles) from April 2012 until its merger with analysis
THOMAS H. IMS Health in December 2016 to create IQVIA (NYSE:IQV). Mr. Pike • Significant mentorship, business
led Quintiles through a successful public offering and helped grow and operating experience in a
PIKE into a Fortune 500 company. Prior to Quintiles, Mr. Pike spent public company
22 years at Accenture (NYSE: ACN), a leading global professional
Director Since: 2019 services company, providing a broad range of services and • Valuable knowledge of financial
Age: 64 solutions in strategy, consulting, digital, technology and system management, public
company accounting, disclosure
Committees: operations, until December 2009. At Accenture, Mr. Pike’s roles requirements and financial
included serving as Chief Risk Officer and Managing Director of the markets
North America Health and Products business areas. He previously
served as the global Chief Operating Officer for Accenture’s
Resources operating group and had also served as Accenture’s
Chief Strategy Officer. Early in his career Mr. Pike was a consultant
with McKinsey & Company. Mr. Pike earned his Bachelor’s degree
in accounting from the University of Delaware.
Audit Ethics, Environment, Safety Executive Finance Management Development Nominating & Corporate
Committee & Health Committee Committee Committee & Compensation Committee Governance Committee
28 2024 PROXY STATEMENT